Clinical trial
Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
NCT00244634 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00244634 |
|---|---|
| Title | Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age |
| Official title | A Dose-Ranging and Safety Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6 to <17 Years of Age: A 4-Week, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pediatric Hypertension |
| Intervention type | Drug |
| Interventions | candsartan cilexetil |
| Enrollment | 238 |
| Start date | Sep 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Oct 27, 2005 |
| Last update posted | Dec 19, 2007 |
| Countries | Belgium, Hungary, Slovakia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: